미숙아의 정맥영양제 투여에 의한 간기능 부작용 발생에 있어서 Fish Oil 함유 대 Soybean Oil 함유 지방유제의 영향비교

키워드

참고문헌 (47)

1. Zhao, Y, "Safety and efficacy of parenteral fish oil-containing lipid emulsions in premature neonates", J Pediatr Gastroenterol Nutr, 60(6), pp.708~716 (2015)
2. Valentine, C.J, "Enhancing parenteral nutrition therapy for the neonate", Nutr Clin Pract, 22(2), pp.183~193 (2007)
3. Burrin, D.G, "Impact of new-generation lipid emulsions on cellular mechanisms of parenteral nutrition-associated liver disease", Adv Nutr, 5(1), pp.82~91 (2014)
4. 김문진, "극소 저출생 체중아에서 SMOFlipid 의 투여가 미숙아 질환 예방에 미치는 영향:Cholestasis 예방 중심으로", 한국정맥경장영양학회지, 5(2), pp.67~ (2013)
5. Christensen, R.D, "Identifying patients, on the first day of life, at high-risk of developing parenteral nutrition-associated liver disease", J Perinatol, 27(5), pp.284~290 (2007)
6. Bharadwaj, S, "Fish oil-based lipid emulsion : current updates on a promising novel therapy for the management of parenteral nutrition-associated liver disease", Gastroenterol Rep(Oxf), 3(2), pp.110~114 (2015)
7. Rollins, M.D, "Effect of decreased parenteral soybean lipid emulsion on hepatic function in infants at risk for parenteral nutrition-associated liver disease : a pilot study", J Pediatr Surg, 48(6), pp.1348~1356 (2013)
8. Nandivada, P, "Mechanisms for the effects of fish oil lipid emulsions in the management of parenteral nutrition-associated liver disease", Prostaglandins Leukot Essent Fatty Acids, 89(4), pp.153~158 (2013)
9. Lam, H.S, "A double-blind randomised controlled trial of fish oil-based versus soybased lipid preparations in the treatment of infants with parenteral nutrition-associated cholestasis", Neonatology, 105(4), pp.290~296 (2014)
10. Kelly, D.A, "Intestinal failure-associated liver disease: what do we know today?", Gastroenterology, 130(2 Suppl 1), pp.S70~S77 (2006)
11. Beath, S.V, "Parenteral nutritionrelated cholestasis in postsurgical neonates : multivariate analysis of risk factors", J Pediatr Surg, 31(4), pp.604~606 (1996)
12. Nehra, D, "The Prevention and Treatment of Intestinal Failure-associated Liver Disease in Neonates and Children", Surgical Clinics of North America, 91(3), pp.543~563 (2011)
13. Candusso, M, "Outcome and quality of life in paediatric home parenteral nutrition", Current opinion in clinical nutrition &metabolic care, 5(3), pp.309~314 (2002)
14. Javid, P.J, "The route of lipid administration affects parenteral nutritioninduced hepatic steatosis in a mouse model", J Pediatr Surg, 40(9), pp.1446~1453 (2005)
15. Colomb, V, "Role of lipid emulsions in cholestasis associated with long-term parenteral nutrition in children", JPEN J Parenter Enteral Nutr, 24(6), pp.345~350 (2000)
16. Park, K.T, "The use of Omegaven in treating parenteral nutrition-associated liver disease", J Perinatol, 31, pp.S57~S60 (2011)
17. Calkins, K.L, "Complications Associated with Parenteral Nutrition in the Neonate", Clinics in Perinatology, 41(2), pp.331~345 (2014)
18. El Kasmi, K.C, "Phytosterols promote liver injury and Kupffer cell activation in parenteral nutrition-associated liver disease", Sci Transl Med, 5(206), pp.206~137 (2013)
19. Clayton, P, "The Role of Phytosterols in the Pathogenesis of Liver Complications of Pediatric Parenteral Nutrition", Nutrition, 14(1), pp.158~164 (1998)
20. Colomb, V, "Liver disease associated with long-term parenteral nutrition in children", Transplant Proc, 26(3), pp.1467~ (1994)
21. Diamond, I.R, "The rationale for the use of parenteral omega-3 lipids in children with short bowel syndrome and liver disease", Pediatr Surg Int, 24(7), pp.773~778 (2008)
22. Guglielmi, F.W, "Cholestasis induced by total parenteral nutrition", Clin Liver Dis, 12(1), pp.97~110 (2008)
23. Carlson, S.E, "Essentiality of omega 3 fatty acids in growth and development of infants", World Rev Nutr Diet, 66, pp.74~86 (1991)
24. Simopoulos, A, "Omega-3 Fatty Acids in Inflammation and Autoimmune Diseases", Journal of the American College of Nutrition, 21(6), pp.495~505 (2002)
25. Lee, S.I, "Impact of fish oil-based lipid emulsion on serum triglyceride, bilirubin, and albumin levels in children with parenteral nutrition-associated liver disease", Pediatr Res, 66(6), pp.698~703 (2009)
26. Kubota, A, "Total parenteral nutrition-associated intrahepatic cholestasis in infants : 25 years’experience", J Pediatr Surg, 35(7), pp.1049~1051 (2000)
27. Merritt, R, "ASPEN nutrition support practice manual", ~ (2005)
28. Wanten, G.J, "Immune modulation by parenteral lipid emulsions", Am J Clin Nutr, 85(5), pp.1171~1184 (2007)
29. Krohn, K, "Parenteral lipid emulsions in paediatrics", Current opinion in clinical nutrition & metabolic care, 9(3), pp.319~323 (2006)
30. Rayyan, M, "Short-term use of parenteral nutrition with a lipid emulsion containing a mixture of soybean oil, olive oil, medium-chain triglycerides, and fish oil : a randomized double-blind study in preterm infants", JPEN J Parenter Enteral Nutr, 36, pp.81~94 (2012)
31. 정혜련, "단일 기관에서 지방유제 단독 제형 투여처방의 적절성 평가", 한국정맥경장영양학회지, 6(3), pp.108~ (2014)
32. Riskin, A, "Parenteral Nutrition in Very Low Birth Weight Preterm Infants", The Israel Medical Association journal, 17(5), pp.310~315 (2015)
33. Nandivada, P, "Treatment of parenteral nutrition-associated liver disease : the role of lipid emulsions", Adv Nutr, 4(6), pp.711~717 (2013)
34. Meisel, J.A, "Comparison of 5 intravenous lipid emulsions and their effects on hepatic steatosis in a murine model", J Pediatr Surg, 46(4), pp.666~673 (2011)
35. Muto, M, "Supplemental Parenteral Vitamin E Into Conventional Soybean Lipid Emulsion Does Not Prevent Parenteral Nutrition-Associated Liver Disease in Full-Term Neonatal Piglets", JPEN J Parenter Enteral Nutr (2015)
36. Sanchez, S.E, "The effect of lipid restriction on the prevention of parenteral nutrition-associated cholestasis in surgical infants", J Pediatr Surg, 48(3), pp.573~578 (2013)
37. Cowles, R.A, "Reversal of intestinal failure-associated liver disease in infants and children on parenteral nutrition : experience with 93 patients at a referral center for intestinal rehabilitation", J Pediatr Surg, 45(1), pp.84~88 (2010)
38. Cober, M.P, "Intravenous fat emulsions reduction for patients with parenteral nutrition-associated liver disease", J Pediatr, 160(3), pp.421~427 (2012)
39. Jump, D.B, "N-3 polyunsaturated fatty acid regulation of hepatic gene transcription", Curr Opin Lipidol, 19(3), pp.242~247 (2008)
40. Jump, D.B, "Multiple mechanisms for polyunsaturated fatty acid regulation of hepatic gene transcription", Prostaglandins Leukot Essent Fatty Acids, 60(5-6), pp.345~349 (1999)
41. Gura, K.M, "Reversal of parenteral nutrition-associated liver disease in two infants with short bowel syndrome using parenteral fish oil : implications for future management", Pediatrics, 118(1), pp.197~201 (2006)
42. Puder, M, "Parenteral fish oil improves outcomes in patients with parenteral nutrition-associated liver injury", Ann Surg, 250(3), pp.395~402 (2009)
43. Gura, K.M, "Safety and efficacy of a fish-oil-based fat emulsion in the treatment of parenteral nutrition-associated liver disease", Pediatrics, 121(3), pp.678~686 (2008)
44. Tomsits, E, "Safety and efficacy of a lipid emulsion containing a mixture of soybean oil, medium-chain triglycerides, olive oil, and fish oil: a randomised, double-blind clinical trial in premature infants requiring parenteral nutrition", J Pediatr Gastroenterol Nutr, 51(4), pp.514~521 (2010)
45. Ziegler, E, "Body composition of the reference fetus", Growth, 40(4), pp.329~341 (1976)
46. Gura, K, "The role of an intravenous fat emulsion composed of fish oil in a parenteral nutrition-dependent patient with hypertriglyceridemia", Nutr Clin Pract, 22(6), pp.664~672 (2007)
47. Fallon, E, "Prevention of parenteral nutrition-associated liver disease : role of ω-3 fish oil", Current opinion in organ transplantation, 15(3), pp.334~340 (2010)

관련 논문AI추천